AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2020
Feb 18, 2020
29821_dirs_2020-02-18_56eabed6-f93e-4525-9c0b-c543cbd59c86.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2020-02-17
Reporting Person: Scanlon Meghan (SVP,Pres,Urology Pelvic Health)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 7321.0000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Deferred Stock Units | $ | 2023-02-15 | Common Stock (3323.0000) | Direct | |
| Deferred Stock Units | $ | 2023-02-21 | Common Stock (3115.0000) | Direct | |
| Deferred Stock Units | $ | 2021-02-22 | Common Stock (2318.0000) | Direct | |
| Deferred Stock Units | $ | 2020-02-23 | Common Stock (1227.0000) | Direct | |
| Deferred Stock Units | $ | 2022-02-28 | Common Stock (3055.0000) | Direct | |
| Deferred Stock Units | $ | 2023-05-01 | Common Stock (8246.0000) | Direct | |
| Deferred Stock Units | $ | 2021-07-01 | Common Stock (1709.0000) | Direct | |
| Stock Option (Right to Buy) | $17.2600 | 2026-02-22 | Common Stock (16450.0000) | Direct | |
| Stock Option (Right to Buy) | $23.4100 | 2026-07-01 | Common Stock (13850.0000) | Direct | |
| Stock Option (Right to Buy) | $24.5500 | 2027-02-28 | Common Stock (18037.0000) | Direct | |
| Stock Option (Right to Buy) | $27.0900 | 2028-02-15 | Common Stock (18007.0000) | Direct | |
| Stock Option (Right to Buy) | $40.1200 | 2029-02-21 | Common Stock (10757.0000) | Direct |
Footnotes
F1: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
F2: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
F3: This amount represents the unvested portion of DSUs awarded on February 15, 2018, which will continue to vest in three remaining installments on the anniversary of the date of grant.
F4: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F5: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.
F6: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
F7: This amount represents the unvested portion of DSUs awarded on February 22, 2016, which will continue to vest in two remaining installments on the anniversary of the date of grant.
F8: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.
F9: This amount represents the unvested portion of DSUs awarded on February 23, 2015, which will continue to vest in one remaining installment on the anniversary of the date of grant.
F10: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.
F11: This amount represents the unvested portion of DSUs awarded on February 28, 2017, which will continue to vest in three remaining installments on the anniversary of the date of grant.
F12: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 1, 2020, the first anniversary of the date of grant.
F13: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on July 1, 2017, the first anniversary of the date of grant.
F14: This amount represents the unvested portion of DSUs awarded on July 1, 2016, which will continue to vest in two remaining installments on the anniversary of the date of grant.
F15: Grant to the reporting person of an option to purchase 18,450 shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
F16: Grant to the reporting person of an option to purchase 13,850 shares of common stock vesting in four equal annual installments beginning on July 1, 2017, the first anniversary of the date of grant.
F17: Grant to the reporting person of an option to purchase 18,037 shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.
F18: Grant to the reporting person of an option to purchase 18,007 shares of common stock vesting in four equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
F19: Grant to the reporting person of an option to purchase 10,757 shares of common stock vesting in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.